← ANALYST RATINGS · TIPRANKS
AptarGroup (ATR): analyst forecast and price target
Analyst consensus
Moderate Buy3 Buy2 Hold0 Sell
Ratings of 5 analysts in the last 3 months12-month forecast
Based on 5 price targets given in the last 3 months, the average target is $148, the highest $155, the lowest $135. The average is +19.3% from the last price of $125.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Anojja Shah★★★★★★★★★★#9062 · hits 38% · avg −1.6% | UBS | $135 | Hold | +8.4% | Initiated | 09.10.26on TipRanks 08:35 | −1.8%next day −1.1% · 5 days +5.4% | ↗ |
| Gabrial Hajde★★★★★★★★★★#4016 · hits 57% · avg +2.6% | Wells Fargo | $155 | Buy | +24.5% | Reiterated | 07.10.26on TipRanks 17:10 | +1.6%next day −1.8% · 5 days +2.3% | ↗ |
| Justin Bowers★★★★★★★★★★#8679 · hits 47% · avg 0.0% | Deutsche Bank | $150 | Buy | +20.5% | Initiated | 07.10.26on TipRanks 09:10 | +0.4%next day +1.6% · 5 days +0.8% | ↗ |
| George Staphos★★★★★★★★★★#3138 · hits 49% · avg +3.4% | Bank of America Securities | $172 → $154−10.5% | Buy | +23.7% | Reiterated | 05.10.26on TipRanks Oct 6 06:30 | −0.1%next day −0.8% · 5 days −1.8% | ↗ |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $155 → $134−13.5% | Hold | +7.6% | Downgrade | 22.09.26on TipRanks 02:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $149 → $129−13.4% | Hold | +3.6% | Downgrade | 22.09.26on TipRanks 02:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $147 → $134−8.8% | Hold | +7.6% | Reiterated | 22.09.26on TipRanks 02:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $143 → $128−10.5% | Hold | +2.8% | Reiterated | 22.09.26on TipRanks 02:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $151 → $131−13.2% | Hold | +5.2% | Downgrade | 22.09.26on TipRanks 02:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $149 → $136−8.7% | Buy | +9.2% | Reiterated | 22.09.26on TipRanks 02:05 | — | |
| Gabrial Hajde★★★★★★★★★★#4016 · hits 57% · avg +2.6% | Wells Fargo | $145 → $155+6.9% | Buy | +24.5% | Reiterated | 03.08.26on TipRanks 07:01 | +0.7%next day −2.2% · 5 days −4.3% | ↗ |
| Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% | William Blair | — | Hold | — | Assigned | 31.07.26on TipRanks 05:10 | −0.7%next day +0.7% · 5 days −2.4% | ↗ |
| Matt Roberts★★★★★★★★★★#8780 · hits 48% · avg −0.2% | Raymond James | $150 → $160+6.7% | Buy | +28.5% | Reiterated | 15.07.26on TipRanks 08:13 | +0.3%next day +4.9% · 5 days +1.0% | ↗ |
| Nico Chen★★★★★★★★★★#2913 · hits 59% · avg +9.8% | DBS | $170 | Buy | +36.5% | Reiterated | 18.03.26on TipRanks Mar 19 08:00 | −2.7%next day 0.0% · 5 days +1.7% | ↗ |
| Ghansham Panjabi★★★★★★★★★★#1720 · hits 57% · avg +5.3% | Robert W. Baird | $145 → $156+7.6% | Buy | +25.3% | Reiterated | 09.02.26on TipRanks 07:20 | +2.6%next day +1.5% · 5 days +3.9% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering AptarGroup
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 06.10.26: target $156 at a price of $121 (+29.6%); now: $148 at $125 (+19.3%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 3 | 5 | 6 | 5 | 5 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.47 (from $1.45 to $1.49). Last quarter: $1.42.
Sales
Next quarter’s sales estimate — $981M (from $957M to $999M). Last quarter: $1.0B.
Best top-analyst consensus in the sector · Healthcare
About AptarGroup
- CEO: Gael Touya
- Employees: 14,000
- 265 Exchange Drive, Crystal Lake, IL, 60014, US
- www.aptar.com
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Data from the stock’s TipRanks forecast page, read 134 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗